Kathryn Oliver

Kathryn Oliver has a diverse work experience spanning across various companies and roles. Kathryn is currently working as a Project Manager at Eliem Therapeutics since August 2021. Prior to this, they worked at RXCELERATE LIMITED as a Project Manager from January 2019 to July 2021, and as a Project Coordinator from March 2017 to December 2018.

Before RXCELERATE LIMITED, Kathryn worked at Cambridge University Hospitals NHS Foundation Trust in different roles, including Patient Public Involvement (PPI) Lead from September 2016 to February 2017, Theme Coordinator - NIHR Rare Diseases - TRC from March 2015 to February 2017, and Clinical Trial Coordinator from November 2012 to March 2015.

Kathryn'searlier experience includes working as a Research Scientist at Cellzome from June 2008 to July 2012 and as a Graduate Chemist at Cambridge Biotechnology Ltd from June 2006 to June 2008. Kathryn also had an industrial placement at UCB Pharma from 2004 to 2005.

Overall, Kathryn Oliver has a strong background in project management and coordination, clinical trials, and research in the pharmaceutical and healthcare sectors.

Kathryn Oliver's education history includes a Bachelor of Science (BSc) degree in Chemistry with Industry from The University of Sheffield. This degree was obtained between 2002 and 2006. No further information is available regarding their education beyond this period.